REHOVOT, Israel, Nov. 2, 2016 /PRNewswire/ -- Nova Measuring Instruments (Nasdaq: NVMI), a leading innovator and a key provider of metrology solutions for advanced process control used in semiconductor manufacturing, today reported financial results for the third quarter of 2016, the period ended September 30, 2016.

Third Quarter 2016 Highlights:


    --  Quarterly revenues grew 24% sequentially to record high of $44.1
        million, up 9% year over year, exceeding the high end of the guidance
    --  GAAP net loss of $4.8 million, or $0.18 per diluted share, inclusive of
        the non-recurring expense of $12.9 million related to royalty payment to
        the Israeli Office of the Chief Scientist
    --  Non-GAAP net income of $9.4 million, or $0.34 per diluted share, up 100%
        sequentially and 49% year over year, exceeding the high end of the
        guidance
    --  Continued penetration into the memory segment yielded two leading memory
        customers contributing more than 10% each to the quarterly products
        revenues


                                          GAAP Results ($K)
                                          ----------------

                                          Q3 2016                   Q2 2016         Q3 2015
                                          -------                   -------         -------

    Revenues                                                $44,060         $35,575         $40,446
    --------                                                -------         -------         -------

    Net Income (Loss)                                      $(4,778)         $3,153          $5,437
    ----------------                                        -------          ------          ------

    Earnings (Loss) per Diluted Share                       $(0.18)          $0.11           $0.20
    ---------------------------------                        ------           -----           -----

                                      NON-GAAP Results ($K)
                                      --------------------

                                          Q3 2016                   Q2 2016         Q3 2015
                                          -------                   -------         -------

    Net Income                                               $9,449          $4,703          $6,316
    ----------                                               ------          ------          ------

    Earnings per Diluted Share                                $0.34           $0.17           $0.23
    --------------------------                                -----           -----           -----

A reconciliation between GAAP operating results and non-GAAP operating results is provided following the financial statements that are part of this release. Non-GAAP results exclude amortization of acquired intangible assets, net adjustments of deferred tax assets, stock-based compensation expenses, expense related to royalty buyout agreement with the Office of the Chief Scientist and inventory write-off.

Management Comments

"It was a strong and well-executed quarter for Nova as we delivered significant growth in revenue and non-gaap profitability, exceeding our guidance," commented Eitan Oppenhaim, President and Chief Executive Officer of Nova. "Strong demand across the entire breadth of our product offering in multiple segments drove record quarterly revenue, reinforcing our confidence in a strong second-half and positions us for another growth year. We are encouraged by our expanding market position, as we continue to solidify our Foundry presence while making significant inroads into the Memory space. This progress is evident by this quarter's diversified customer mix that included four customers contributing more than 10% each to the quarterly products revenues, including two leading memory customers."

Mr. Oppenhaim added, "During the quarter we continued to leverage our financial strength to maximize shareholder value, signing a royalty buyout agreement with the Israeli Office of the Chief Scientist, eliminating approximately $24 million in future obligations. The agreement, coupled with our efficient operational model, will enhance our financial flexibility and will allow us to invest in sustainable, profitable growth. As evident from this quarter's results, our efforts are already bearing fruit, demonstrating that we are on a clear path toward achieving our long-term profitability target."

2016 Fourth Quarter Financial Outlook

Management provided an outlook for the fourth quarter, the period ending December 31, 2016. Based on current estimates, management expects:


    --  $42 million to $46 million in revenue
    --  $0.23 to $0.29 in diluted GAAP EPS
    --  $0.31 to $0.40 in diluted non-GAAP EPS

2016 Third Quarter Results

Total revenues for the third quarter of 2016 were $44.1 million, an increase of 24% compared to the second quarter of 2016, and an increase of 9% relative to the third quarter of 2015.

Gross margin for the third quarter of 2016 was 22%, and included $12.9 million of expense related to royalty buyout agreement with the Office of the Chief Scientist (currently known as the National Authority for Technological Innovation) and $1.9 million of expense related to inventory write-off. This is compared with gross margin of 53% in the second quarter of 2016 and compared with gross margin of 56% in the third quarter of 2015.

Operating expenses in the third quarter of 2016 were $16.6 million. This is compared with $15.4 million in the second quarter of 2016 and compared with $17.4 million in the third quarter of 2015.

On a GAAP basis, which included $12.9 million of expense related to royalty buyout agreement with the Office of the Chief Scientist and $1.9 million of expense related to inventory write-off, the company reported net loss of $4.8 million, or $0.18 loss per diluted share, in the third quarter of 2016. This is compared with net income of $3.2 million, or $0.11 per diluted share, in the second quarter of 2016. The company reported net income of $5.4 million, or $0.20 per diluted share, in the third quarter of 2015.

On a Non-GAAP basis, which excludes amortization of acquired intangible assets, net adjustments of deferred tax assets, stock-based compensation expenses, expense related to royalty buyout agreement with the Office of the Chief Scientist and inventory write-off, the company reported net income of $9.4 million, or $0.34 per diluted share, in the third quarter of 2016. This is compared with net income of $4.7 million, or $0.17 per diluted share, in the second quarter of 2016, and compared with net income of $6.3 million, or $0.23 per diluted share, in the third quarter of 2015.

Conference Call Information

Nova will host a conference call today, November 2, 2016, at 9 a.m. Eastern Time, to discuss the financial results and future outlook. To attend the conference call, please dial one of the following teleconferencing numbers. Please begin by placing your calls five minutes before the conference call commences. If you are unable to connect using the toll-free numbers, please try the international dial-in number.

U.S. Dial-in Number: 1-888-428-9480
ISRAEL Dial-in Number: 1 80 924 6042
INTERNATIONAL Dial-in Number: 1-719-457-2628
At:
9 a.m. Eastern Time
6 a.m. Pacific Time
3 p.m. Israeli Time

Please reference conference ID 2393527

The conference call will also be webcast live from a link on Nova's website at http://ir.novameasuring.com.

About Nova: Nova Measuring Instruments delivers continuous innovation by providing advanced metrology solutions for the semiconductor manufacturing industry. Deployed with the world's largest integrated-circuit manufacturers, Nova's products deliver state-of-the-art, high-performance metrology solutions for effective process control throughout the semiconductor fabrication lifecycle. Nova's product portfolio, which combines high-precision hardware and cutting-edge software, supports the development and production of the most advanced devices in today's high-end semiconductor market. Nova's technical innovation and market leadership enable customers to improve process performance, enhance products' yields and accelerate time to market. Nova acts as a partner to semiconductor manufacturers from its offices around the world. Additional information may be found at www.novameasuring.com.

Nova is traded on the NASDAQ & TASE under the symbol NVMI.

This press release provides financial measures that exclude charges for amortization of acquired intangible assets, net adjustment of deferred tax assets, stock-based compensation expenses, acquisition related expenses, expense related to royalty buyout agreement with the Office of the Chief Scientist and inventory write-off and are therefore not calculated in accordance with generally accepted accounting principles (GAAP). Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding Nova's performance because they reflect our operational results and enhances management's and investors' ability to evaluate Nova's performance before charges or benefits considered by management to be outside Nova's ongoing operating results. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management believes that it is in the best interest of its investors to provide financial information that will facilitate comparison of both historical and future results and allows greater transparency to supplemental information used by management in its financial and operational decision making. A reconciliation of each GAAP to non-GAAP financial measure discussed in this press release is contained in the accompanying financial tables.

This press release contains forward-looking statements within the meaning of safe harbor provisions of the Private Securities Litigation Reform Act of 1995 relating to future events or our future performance, such as statements regarding, but are not limited to, anticipated growth opportunities and projections about our business and its future revenues, expenses and profitability. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied in those forward looking statements. Factors that may affect our results, performance, circumstances or achievements include, but are not limited to, the following: our dependency on three product lines; our dependency on a small number of large customers and small number of suppliers; the highly cyclical and competitive nature of the markets we target and we operate in; our inability to reduce spending during a slowdown in the semiconductor industry; our ability to respond effectively on a timely basis to rapid technological changes; our ability to recognize the benefits of ReVera acquisition and risks that the acquisition may disrupt current plans and operations and impact relationships with customers, distributors and suppliers; our dependency on PEMs; risks related to exclusivity obligations and non-limited liability that may be included in our commercial agreements and arrangements; our ability to retain our competitive position despite the ongoing consolidation in our industry; risks related to our dependence on our manufacturing facilities; risks related to changes in our order backlog; risks related to the worldwide financial instabilities; risks related to our intellectual property; new product offerings from our competitors; unanticipated manufacturing or supply problems; risks related to government programs we participate in; risks related to taxation; changes in customer demand for our products; risks related to currency fluctuations, risks related to acquisitions we may pursue and risks related to our operations in Israel. We cannot guarantee future results, levels of activity, performance or achievements. The matters discussed in this press release also involve risks and uncertainties summarized under the heading "Risk Factors" in Nova's Annual Report on Form 20-F for the year ended December 31, 2015 filed with the Securities and Exchange Commission on February 29, 2016. These factors are updated from time to time through the filing of reports and registration statements with the Securities and Exchange Commission. Nova Measuring Instruments Ltd. does not assume any obligation to update the forward-looking information contained in this press release.

(Tables to Follow)




                                        NOVA MEASURING INSTRUMENTS LTD.
                                        -------------------------------

                                     CONDENSED CONSOLIDATED BALANCE SHEETS
                                     -------------------------------------

                                   (U.S. dollars in thousands) - (Unaudited)


                                                                                           As of
                                                                                           -----

                                                                             September 30,     December 31,

    ASSETS                                                                            2016              2015

                                                                                                 (Audited)
                                                                                                 --------



    Current assets

    Cash and cash equivalents                                                       23,654            27,733

    Short-term interest-bearing
     bank deposits                                                                  69,548            69,298

    Trade accounts receivable                                                       23,558            19,046

    Inventories                                                                     28,889            27,683

    Deferred tax assets                                                              4,773             3,540

    Other current assets                                                             3,472             2,888
                                                                                     -----             -----


    Total current assets                                                           153,894           150,188
                                                                                   -------           -------


    Long-term assets

    Long-term interest-bearing
     bank deposits                                                                     750               750

    Deferred tax assets                                                              5,284             5,735

    Severance pay funds                                                              1,485             1,514

    Property and equipment, net                                                      9,266            11,062

    Identifiable intangible
     assets, net                                                                    15,997            17,906

    Goodwill                                                                        20,114            20,114
                                                                                    ------            ------


    Total long-term assets                                                          52,896            57,081
                                                                                    ------            ------


    Total assets                                                                   206,790           207,269
                                                                                   =======           =======


     Liabilities and shareholders'
      Equity

    Current liabilities

    Trade accounts payable                                                          12,374            14,378

    Deferred revenues                                                                4,423             5,828

    Deferred tax liabilities                                                         1,064               956

    Other current liabilities                                                       15,352            15,996
                                                                                    ------            ------


    Total current liabilities                                                       33,213            37,158
                                                                                    ------            ------


    Long-term liabilities

    Deferred tax liabilities                                                         5,039             5,760

    Liability for employee
     severance pay                                                                   2,535             2,469

    Other long-term liabilities                                                        921               822
                                                                                       ---               ---


    Total long-term liabilities                                                      8,495             9,051
                                                                                     -----             -----


    Shareholders' equity                                                           165,082           161,060
                                                                                   -------           -------


    Total liabilities and
     shareholders' equity                                                          206,790           207,269
                                                                                   =======           =======



                                                                                       NOVA MEASURING INSTRUMENTS LTD.
                                                                                       -------------------------------

                                                                               CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                                                               -----------------------------------------------

                                                                       (U.S. dollars in thousands, except per share data) - (Unaudited)


                                                                                                                                        Three months ended Nine months ended
                                                                                                                                        ------------------ -----------------

                                                                                                                                           September 30,     September 30,    September 30,   September 30,
                                                                                                                                                      2016               2015            2016             2015
                                                                                                                                                      ----               ----            ----             ----


    Revenues:

    Products                                                                                                                                        32,944             30,412          82,633           80,597

    Services                                                                                                                                        11,116             10,034          31,058           27,895
                                                                                                                                                    ------             ------          ------           ------

    Total revenues                                                                                                                                  44,060             40,446         113,691          108,492
                                                                                                                                                    ------             ------         -------          -------


    Cost of revenues:

    Products                                                                                                                                        13,127             12,610          33,080           34,592

    Services                                                                                                                                         6,476              5,189          18,725           15,219

    Expense related to royalty buyout agreement with the Office of the
     Chief Scientist

                                                                                                                                                    12,875                  -         12,875                -

    Inventory write-off                                                                                                                              1,889                  -          1,889                -

    Amortization of acquired intangible assets in cost of products

                                                                                                                                                         -                13               -           2,455
                                                                                                                                                       ---               ---             ---           -----

    Total cost of revenues                                                                                                                          34,367             17,812          66,569           52,266
                                                                                                                                                    ------             ------          ------           ------


    Gross profit                                                                                                                                     9,693             22,634          47,122           56,226


    Operating expenses:

    Research and development
     expenses, net                                                                                                                                   9,181             10,974          25,773           28,877

    Sales and marketing
     expenses                                                                                                                                        5,020              4,228          14,922           11,294

    General and administration
     expenses                                                                                                                                        1,802              1,613           5,133            4,250

    Acquisition related
     expenses                                                                                                                                            -                 -              -           2,655

    Amortization of acquired
     intangible assets                                                                                                                                 637                570           1,909            1,139
                                                                                                                                                       ---                ---           -----            -----

    Total operating expenses                                                                                                                        16,640             17,385          47,737           48,215
                                                                                                                                                    ------             ------          ------           ------


    Operating income (loss)                                                                                                                        (6,947)             5,249           (615)           8,011


    Financing income, net                                                                                                                              301                 94           1,026              459
                                                                                                                                                       ---                ---           -----              ---


    Income (loss) before tax
     on income                                                                                                                                     (6,646)             5,343             411            8,470


    Income tax expenses
     (benefit)                                                                                                                                     (1,868)              (94)          (869)         (2,094)
                                                                                                                                                    ------                ---            ----           ------


    Net income (loss) for the
     period                                                                                                                                        (4,778)             5,437           1,280           10,564
                                                                                                                                                    ======              =====           =====           ======


    Earnings (loss) per share:

    Basic                                                                                                                                           (0.18)              0.20            0.05             0.39
                                                                                                                                                     =====               ====            ====             ====

    Diluted                                                                                                                                         (0.18)              0.20            0.05             0.38
                                                                                                                                                     =====               ====            ====             ====


    Shares used for calculation of earnings (loss) per share:


    Basic                                                                                                                                           27,169             27,172          27,136           27,224
                                                                                                                                                    ======             ======          ======           ======

    Diluted                                                                                                                                         27,169             27,481          27,361           27,507
                                                                                                                                                    ======             ======          ======           ======


                                                                                    NOVA MEASURING INSTRUMENTS LTD.
                                                                                    -------------------------------

                                                                            CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                                                            -----------------------------------------------

                                                                               (U.S. dollars in thousands) - (Unaudited)


                                                                                                                            Three months ended       Nine months ended


                                                                                                                               September 30,           September 30,    September 30,   September 30,
                                                                                                                                          2016                     2015            2016             2015
                                                                                                                                          ----                     ----            ----             ----

    Cash flows from operating activities:

    Net income (loss) for the period                                                                                                   (4,778)                   5,437           1,280           10,564


    Adjustments to reconcile net income to net cash
    provided by (used in) operating activities:

    Depreciation                                                                                                                         1,191                    1,103           3,540            3,309

    Amortization of acquired intangible assets                                                                                             637                      583           1,909            3,594

    Amortization of deferred stock-based compensation                                                                                      639                      778           2,044            1,908

    Increase (decrease) in liability for employee termination benefits, net                                                                (1)                    (49)             95               35

    Deferred tax assets, net                                                                                                           (1,813)                   (482)        (1,395)         (2,969)

    Loss on securities                                                                                                                       -                      81               -              13

    Increase in trade accounts receivable                                                                                                (783)                 (1,873)        (4,512)         (6,256)

    Decrease (increase) in inventories                                                                                                   1,722                  (1,431)        (1,335)         (2,694)

    Increase in other current and long term assets                                                                                       (687)                   (459)          (295)           (502)

    Increase (decrease) in trade accounts payable                                                                                        (760)                 (2,428)        (2,004)             135

    Increase (decrease) in other current and other long-term liabilities                                                                 2,043                    1,964           (564)           2,646

    Increase (decrease) in short and long term deferred revenues                                                                           701                    4,132         (1,405)           3,289
                                                                                                                                           ---                    -----          ------            -----


    Net cash provided by (used in) operating activities                                                                                (1,889)                   7,356         (2,642)          13,072
                                                                                                                                        ------                    -----          ------           ------


    Cash flow from investment activities:

    Decrease (increase) in short-term interest-bearing bank deposits                                                                           (450)

                                                                                                                                         5,682                                   (250)          48,036

    Acquisition of subsidiary, net of acquired cash                                                                                          -                       -              -        (45,344)

    Additions to property and equipment                                                                                                  (535)                   (644)        (1,615)         (2,168)
                                                                                                                                          ----                     ----          ------           ------


    Net cash provided by (used in) investment activities                                                                                 5,147                  (1,094)        (1,865)             524
                                                                                                                                         -----                   ------          ------              ---


    Cash flows from financing activities:

    Purchases of treasury shares                                                                                                             -                 (2,913)          (937)         (4,302)

    Shares issued under employee stock-based plans                                                                                         941                      138           1,365            2,087
                                                                                                                                           ---                      ---           -----            -----


    Net cash provided by (used in) financing activities                                                                                    941                  (2,775)            428          (2,215)
                                                                                                                                           ---                   ------             ---           ------


    Increase (decrease) in cash and cash equivalents                                                                                     4,199                    3,487         (4,079)          11,381

    Cash and cash equivalents - beginning of period                                                                                     19,455                   21,543          27,733           13,649
                                                                                                                                        ------                   ------          ------           ------

    Cash and cash equivalents - end of period                                                                                           23,654                   25,030          23,654           25,030
                                                                                                                                        ======                   ======          ======           ======



                                                                                 NOVA MEASURING INSTRUMENTS LTD.
                                                                                 -------------------------------

                                                                           RECONCILIATION OF GAAP TO NON-GAAP RESULTS
                                                                           ------------------------------------------

                                                         (U.S. dollars in thousands, except percentage and per share data) - (Unaudited)


                                                            Three months ended
                                                          ------------------

                                                       September  30,                                      June 30,                      September 30,
                                                                              2016                                      2016                              2015
                                                                              ----                                      ----                              ----

    GAAP cost of
     revenues                                                               34,367                                    16,676                            17,812

      Amortization of
       acquired
       intangible assets
       in cost of
       products                                                                  -                                        -                             (13)

      Expense related to royalty buyout agreement with the Office
       of the Chief Scientist

                                                                          (12,875)                                        -                                -

      Inventory write-
       off                                                                 (1,889)                                        -                                -

      Stock-based
       compensation in
       cost of products                                                       (79)                                     (79)                            (109)

      Stock-based
       compensation in
       cost of services                                                       (52)                                     (48)                             (62)
                                                                               ---                                       ---                               ---

    Non-GAAP cost of
     revenues                                                               19,472                                    16,549                            17,628
                                                                            ======                                    ======                            ======


    GAAP gross profit                                                        9,693                                    18,899                            22,634

    Gross profit
     adjustments                                                            14,895                                       127                               184
                                                                            ------                                       ---                               ---

    Non-GAAP gross
     profit                                                                 24,588                                    19,026                            22,818
                                                                            ======                                    ======                            ======

    GAAP gross margin as
     a percentage of
     revenues                                                                  22%                                      53%                              56%

    Non-GAAP gross
     margin as a
     percentage of
     revenues                                                                  56%                                      53%                              56%


    GAAP operating
     expenses                                                               16,640                                    15,376                            17,385

      Stock-based
       compensation in
       research and
       development                                                           (200)                                    (230)                            (318)

      Stock-based
       compensation in
       sales and
       marketing                                                             (226)                                    (237)                            (205)

      Stock-based
       compensation in
       general and
       administrative                                                         (82)                                     (55)                             (84)

      Amortization of
       acquired
       intangible assets                                                     (637)                                    (636)                            (570)
                                                                              ----                                      ----                              ----

    Non-GAAP operating
     expenses                                                               15,495                                    14,218                            16,208
                                                                            ------                                    ------                            ------

    Non-GAAP operating
     income                                                                  9,093                                     4,808                             6,610
                                                                             =====                                     =====                             =====

    GAAP operating
     margin as a
     percentage of
     revenues                                                                (16%)                                      10%                              13%

    Non-GAAP operating
     margin as a
     percentage of
     revenues                                                                  21%                                      14%                              16%


    GAAP tax on income                                                     (1,868)                                      626                              (94)

      Deferred tax assets
       adjustments, net                                                      1,813                                     (265)                              482
                                                                             -----                                      ----                               ---

    Non-GAAP tax on
     income                                                                   (55)                                      361                               388
                                                                               ===                                       ===                               ===


    GAAP net income
     (loss)                                                                (4,778)                                    3,153                             5,437

      Amortization of
       acquired
       intangible assets                                                       637                                       636                               583

      Expense related to
       royalty buyout
       agreement with the
       Office of the
       Chief Scientist                                                      12,875                                         -                                -

      Stock-based
       compensation
       expenses                                                                639                                       649                               778

      Deferred tax assets
       adjustments, net                                                    (1,813)                                      265                             (482)

      Inventory write-
       off                                                                   1,889                                         -                                -

    Non-GAAP net income                                                      9,449                                     4,703                             6,316
                                                                             =====                                     =====                             =====


    GAAP basic earnings
     (loss) per share                                                       (0.18)                                     0.12                              0.20
                                                                             =====                                      ====                              ====

    Non-GAAP basic
     earnings per share                                                       0.35                                      0.17                              0.23
                                                                              ====                                      ====                              ====


    GAAP diluted
     earnings (loss)
     per share                                                              (0.18)                                     0.11                              0.20
                                                                             =====                                      ====                              ====

    Non-GAAP diluted
     earnings per share                                                       0.34                                      0.17                              0.23
                                                                              ====                                      ====                              ====


    Shares used for calculation of earnings (loss) per share:

      Basic                                                                 27,169                                    27,123                            27,172
                                                                            ======                                    ======                            ======

      Diluted                                                               27,536                                    27,422                            27,481
                                                                            ======                                    ======                            ======



    Company Contact:                    Investor Relations Contacts:


    Dror David, Chief Financial Officer Hayden/ MS-IR LLC

    Nova Measuring Instruments Ltd.     Miri Segal

    Tel: +972-73-229-5760               Tel: +917-607-8654

    E-mail: info@novameasuring.com      E-mail: msegal@ms-ir.com

    www.novameasuring.com               Or

                                        Brett Maas

                                        Tel: +646-536-7331

                                        E-mail: brett@haydenir.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nova-reports-record-revenues-for-third-quarter-2016-300355743.html

SOURCE Nova Measuring Instruments